Tag: drug-coated devices
IVUS is “not a free walk” – it is about the patient...
In conversation with Vascular News about IVUS, Eric Secemsky (Beth Israel Deaconess Medical Center, Boston, USA, and a newly appointed editor of Vascular News...
Two-year Ranger DCB data demonstrate “sustained, high rate” of device efficacy
Patients treated with the Ranger drug-coated balloon (DCB; Boston Scientific) sustained “improved primary patency” with fewer reinterventions than those treated with uncoated devices, two-year...
IN.PACT AV DCB sustained “superior” effectiveness in subgroups with high reintervention...
Several subgroups of patients treated with the IN.PACT AV drug-coated balloon (DCB; Medtronic) for arteriovenous fistulas (AVFs) demonstrated a “statistically significant” higher rate of...
